Reliability of Pupil Response to Acute Pain
Launched by WAKE FOREST UNIVERSITY HEALTH SCIENCES · Dec 8, 2015
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how the size of a person's pupils responds to acute pain, specifically in individuals with arthritis in their hips or knees. When someone feels pain, their pupils can change size, and researchers want to see if these changes can reliably indicate how much pain a person is experiencing. This information could help doctors better understand pain and improve treatment options in the future.
To participate in this study, you should be an adult aged 18 to 70 who experiences moderate pain from hip or knee arthritis. You will not be eligible if you have certain medical conditions, are pregnant, or have a history of specific eye surgeries. If you join the trial, you can expect to answer some questionnaires and undergo tests to measure how your pupils respond to pain. This research is currently looking for volunteers, and all genders are welcome to participate.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult (18-70)
- • Pain from hip or knee arthritis of moderate intensity
- • American Society of Anesthesiologists physical status 1-3
- Exclusion Criteria:
- • Inability to complete study questionnaires
- • Pregnancy
- • Litigation or workers compensation related to hip or knee pain
- • Taking \> 50 mg morphine equivalents/day
- • History of Raynaud's disease of the feet
- • Psychotic disorder or a recent psychiatric hospitalization
- • History of eye surgery or topical eye medications that would would directly affect pupil diameter
About Wake Forest University Health Sciences
Wake Forest University Health Sciences is a leading academic research institution dedicated to advancing healthcare through innovative clinical trials and translational research. With a strong emphasis on multidisciplinary collaboration, the organization leverages its extensive expertise in medical research, patient care, and education to develop and evaluate new therapies and interventions. Committed to improving patient outcomes and public health, Wake Forest University Health Sciences fosters a dynamic environment for scientific inquiry, engaging in a wide range of clinical studies that address pressing health challenges. Through its rigorous methodologies and ethical standards, the institution aims to contribute significantly to the medical field and enhance the quality of life for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Winston Salem, North Carolina, United States
Patients applied
Trial Officials
James C Eisenach, MD
Principal Investigator
Wake Forest University Health Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials